Directed issue of shares in Active Biotech (SE) — SEK 340 million

Carnegie acted as adviser to Active Biotech in connection with the directed issue of SEK 340 million to institutional investors. Active Biotech is a biotechnology company focusing on development and distribution of vaccines and research in inflammatory diseases.June, 1998.